keyword
https://read.qxmd.com/read/38701407/abbv-319-a-cd19-targeting-glucocorticoid-receptor-modulator-antibody-drug-conjugate-therapy-for-b-cell-malignancies
#1
JOURNAL ARTICLE
Chewei Anderson Chang, Ethan Emberley, Aloma L D'Souza, Weilong Zhao, Cormac Cosgrove, Karen E Parrish, Diya Mitra, Elmer Payson, Anatol Oleksijew, Paul Ellis, Luis Rodriguez, Ryan Duggan, Cara Hrusch, Loren Lasko, Wissam Assaily, Pingping Zheng, Wei Liu, Axel Hernandez, Kimberley McCarthy, Zhaomei Zhang, Geunbae Rha, Zhensheng Cao, Yingchun Li, Olivia Perng, Jos Campbell, Gloria Zhang, Tyler Scott Curran, Milan Bruncko, Christopher C Marvin, Adrian D Hobson, Michael McPherson, Tamar Uziel, Marybeth A Pysz, Xi Zhao, Alexander Bankovich, Joel Hayflick, Michael McDevitt, Kevin J Freise, Susan Morgan-Lappe, James W Purcell
Glucocorticoids are key components of the current standard-of-care regimens (e.g., R-CHOP, EPOCH-R, Hyper-CVAD) for treatment of B-cell malignancy. However, systemic glucocorticoid treatment is associated with several adverse events. CD19 displays restricted expression in normal B-cells and is up-regulated in B-cell malignancies. ABBV-319 is a CD19-targeting antibody-drug conjugate (ADC) engineered to reduce glucocorticoid-associated toxicities while possessing three distinct mechanisms of action (MOA) to increase therapeutic efficacy: (1) antibody-mediated delivery of glucocorticoid receptor modulator (GRM) payload to activate apoptosis, (2) inhibition of CD19 signaling, and (3) enhanced Fc-mediated effector function via afucosylation of the antibody backbone...
May 3, 2024: Blood
https://read.qxmd.com/read/38645165/interleukin-15-armored-gpc3-car-t-cells-for-patients-with-solid-cancers
#2
Andras Heczey, David Steffin, Nisha Ghatwai, Antonino Montalbano, Purva Rathi, Amy Courtney, Azlann Arnett, Julien Fleurence, Ramy Sweidan, Tao Wang, Huimin Zhang, Prakash Masand, John Maris, Dan Martinez, Jennier Pogoriler, Navin Varadarajan, Sachin Thakkar, Deborah Lyon, Natasha Lapteva, Mei Zhuyong, Kalyani Patel, Dolores Lopez-Terrada, Carlos Ramos, Premal Lulla, Tannaz Armaghany, Bambi Grilley, Gianpietro Dotti, Leonid Metelitsa, Helen Heslop, Malcolm Brenner, Pavel Sumazin
Interleukin-15 (IL15) promotes the survival of T lymphocytes and enhances the antitumor properties of CAR T cells in preclinical models of solid neoplasms in which CAR T cells have limited efficacy1-4. Glypican-3 (GPC3) is expressed in a group of solid cancers5-10, and here we report the first evaluation in humans of the effects of IL15 co-expression on GPC3-CAR T cells. Cohort 1 patients (NCT02905188/NCT02932956) received GPC3-CAR T cells, which were safe but produced no objective antitumor responses and reached peak expansion at two weeks...
April 3, 2024: Research Square
https://read.qxmd.com/read/38579140/ponatinib-and-stat5-inhibitor-pimozide-combined-synergistic-treatment-applications-potentially-overcome-drug-resistance-via-regulating-the-cytokine-expressional-network-in-chronic-myeloid-leukemia-cells
#3
JOURNAL ARTICLE
Burcin Tezcanli Kaymaz, Nurcan Gumus, Besne Celik, İlayda Alcitepe, Cigir Biray Avci, Cagdas Aktan
Chronic myeloid leukemia (CML) is a clonal myeloproliferative hematological disease characterized by the chimeric breakpoint-cluster region/Abelson kinase1 (BCR::ABL1) oncoprotein; playing a pivotal role in CML molecular pathology, diagnosis, treatment, and possible resistance arising from the success and tolerance of tyrosine kinase inhibitor (TKI)-based therapy. The transcription factor STAT5 constitutive signaling, which is influenced by the cytokine signaling network, triggers BCR::ABL1-based CML pathogenesis and is also relevant to acquired TKI resistance...
April 2024: Journal of Interferon & Cytokine Research
https://read.qxmd.com/read/38572955/preclinical-evaluation-of-off-the-shelf-pd-l1-human-natural-killer-cells-secreting-il15-to-treat-non-small-cell-lung-cancer
#4
JOURNAL ARTICLE
Ting Lu, Rui Ma, Anthony G Mansour, Christian Bustillos, Zhiyao Li, Zhenlong Li, Shoubao Ma, Kun-Yu Teng, Hanyu Chen, Jianying Zhang, Miguel A Villalona-Calero, Michael A Caligiuri, Jianhua Yu
We described previously a human natural killer (NK) cell population that upregulates PD-L1 expression upon recognizing and reacting to tumor cells or exposure to a combination of IL12, IL18 and IL15. Here, to investigate the safety and efficacy of tumor-reactive and cytokine-activated (TRACK) NK cells, human NK cells from umbilical cord blood were expanded, transduced with a retroviral vector encoding soluble (s) IL15, and further cytokine activated to induce PD-L1 expression. Our results show cryopreserved and thawed sIL15_TRACK NK cells had significantly improved cytotoxicity against non-small cell lung cancer (NSCLC) in vitro when compared to non-transduced (NT) NK cells, PD-L1+ NK cells lacking sIL15 expression (NT_TRACK NK), or NK cells expressing sIL15 without further cytokine activation (sIL15 NK cells)...
April 3, 2024: Cancer Immunology Research
https://read.qxmd.com/read/38540262/the-htert-and-icasp9-transgenes-affect-eomes-and-t-bet-levels-in-nk-cells-and-the-introduction-of-both-genes-improves-nk-cell-proliferation-in-response-to-il2-and-il15-stimulation
#5
JOURNAL ARTICLE
Anastasia I Palamarchuk, Elena I Kovalenko, Maria A Streltsova
The NK cell exhaustion state evolving during extensive and prolonged cultivation is still one of the limitations of NK cell approaches. In this research, we transduced NK cells with the hTERT and iCasp9 genes. hTERT overexpression can prevent the functional exhaustion of NK cells during long-term cultivation, but, still, the therapeutic use of such cells is unsafe without irradiation. To overcome this obstacle, we additionally transduced NK cells with the iCasp9 transgene that enables the rapid elimination of modified cells...
March 14, 2024: Biomedicines
https://read.qxmd.com/read/38521919/evaluation-of-the-presence-of-gingivitis-as-confounding-factor-in-assessing-inflammatory-status-in-serum-and-saliva-of-dogs-with-diabetes-mellitus
#6
JOURNAL ARTICLE
Lorena Franco-Martinez, Alberto Muñoz-Prieto, Francesca Busato, Birute Karveliene, Inga Stadaliene, Jose J Ceron, Juana D Carrillo, Juan D Garcia-Martinez, Roman Dabrowski, Luis Pardo-Marín, Silvia Martinez-Subiela, Asta Tvarijonaviciute
The aim of this study was to evaluate the changes in the serum and salivary inflammatory markers induced by Diabetes mellitus (DM) in dogs and to assess the possible confounding effect of gingivitis. A panel of 13 cytokines was measured in the serum and saliva of dogs diagnosed with DM and compared with healthy dogs without gingivitis (control group 1; CG1) and dogs with gingivitis but otherwise healthy (control group 2; CG2). The results of the present study showed statistically significantly higher levels of IL-8, KC-like and MCP1 in the serum of dogs with DM compared to CG1 dogs...
March 23, 2024: BMC Veterinary Research
https://read.qxmd.com/read/38515757/efbalropendekin-alfa-enhances-human-natural-killer-cell-cytotoxicity-against-tumor-cell-lines-in-vitro
#7
JOURNAL ARTICLE
Hesham M Shehata, Pranay Dogra, Sarah Gierke, Patrick Holder, Shomyseh Sanjabi
IL-15 has shown preclinical activity by enhancing the functional maturation of natural killer (NK) cells. Clinical evaluation of the potential anticancer activity of most cytokines, including IL-15, has been limited by low tolerability and rapid in vivo clearance. Efbalropendekin Alfa (XmAb24306) is a soluble IL15/IL15-receptor alpha heterodimer complex fused to a half-life extended Fc domain (IL15/IL15Rα-Fc), engineered with mutations to reduce IL-15 affinity for CD122. Reduced affinity drives lower potency, leading to prolonged pharmacodynamic response in cynomolgus monkeys...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38513098/il7-increases-targeted-lipid-nanoparticle-mediated-mrna-expression-in-t-cells-in-vitro-and-in-vivo-by-enhancing-t-cell-protein-translation
#8
JOURNAL ARTICLE
Caitlin M Tilsed, Barzan A Sadiq, Tyler E Papp, Phurin Areesawangkit, Kenji Kimura, Estela Noguera-Ortega, John Scholler, Nicholas Cerda, Haig Aghajanian, Adrian Bot, Barbara Mui, Ying Tam, Drew Weissman, Carl H June, Steven M Albelda, Hamideh Parhiz
The use of lipid nanoparticles (LNP) to encapsulate and deliver mRNA has become an important therapeutic advance. In addition to vaccines, LNP-mRNA can be used in many other applications. For example, targeting the LNP with anti-CD5 antibodies (CD5/tLNP) can allow for efficient delivery of mRNA payloads to T cells to express protein. As the percentage of protein expressing T cells induced by an intravenous injection of CD5/tLNP is relatively low (4-20%), our goal was to find ways to increase mRNA-induced translation efficiency...
March 26, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38457608/identification-of-early-risk-factors-for-anti-citrullinated-protein-antibody-positive-rheumatoid-arthritis-a-prospective-cohort-study
#9
JOURNAL ARTICLE
Alexandra Cîrciumaru, Yogan Kisten, Monika Hansson, Linda Mathsson-Alm, Vijay Joshua, Heidi Wähämaa, Malena Loberg Haarhaus, Joakim Lindqvist, Leonid Padyukov, Sergiu-Bogdan Catrina, Guozhong Fei, Nancy Vivar, Hamed Rezaei, Erik Af Klint, Aleksandra Antovic, Bence Réthi, Anca I Catrina, Aase Hensvold
OBJECTIVE: Individuals positive for anti-cyclic-peptide-antibodies (anti-CCP) and musculoskeletal complaints (MSK-C) are at risk for developing rheumatoid arthritis (RA). In this study we aimed to investigate factors involved in arthritis progression. METHODS: Anti-CCP2-positive individuals with MSK-C referred to a rheumatologist were recruited. Individuals lacked arthritis at clinical and ultrasound examination and were followed for ≥three years or until clinical arthritis diagnosis...
March 8, 2024: Rheumatology
https://read.qxmd.com/read/38392218/the-role-of-rv1476-in-regulating-stress-response-and-intracellular-survival-of-mycobacterium-tuberculosis
#10
JOURNAL ARTICLE
Aikebaier Reheman, Yifan Wang, Huaiyuan Cai, Pingyang Wei, Gang Cao, Xi Chen
The virulence of Mycobacterium tuberculosis ( M. tuberculosis ) is related to many factors, including intracellular survival, cell wall permeability, and cell envelope proteins. However, the biological function of the M. tuberculosis membrane protein Rv1476 remains unclear. To investigate the potential role played by Rv1476 , we constructed an Rv1476 overexpression strain and found that overexpression of Rv1476 enhanced the intracellular survival of M. tuberculosis , while having no impact on the growth rate in vitro...
February 16, 2024: Current Issues in Molecular Biology
https://read.qxmd.com/read/38385283/nanofibrous-multidomain-peptide-hydrogels-provide-t-cells-a-3d-cytocompatible-environment-for-cell-expansion-and-antigen-specific-killing
#11
JOURNAL ARTICLE
Viridiana Leyva-Aranda, Shailbala Singh, Maria J Telesforo, Simon Young, Cassian Yee, Jeffrey D Hartgerink
T cells have the ability to recognize and kill specific target cells, giving therapies based on their potential for treating infection, diabetes, cancer, and other diseases. However, the advancement of T cell-based treatments has been hindered by difficulties in their ex vivo activation and expansion, the number of cells required for sustained in vivo levels, and preferential localization following systemic delivery. Biomaterials may help to overcome many of these challenges by providing a combined means of proliferation, antigen presentation, and cell localization upon delivery...
February 22, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38376769/identification-and-verification-of-inflammatory-biomarkers-for-primary-sj%C3%A3-gren-s-syndrome
#12
JOURNAL ARTICLE
Xiaodan Liu, Haojie Wang, Xiao Wang, Xiaodan Jiang, Yinji Jin, Ying Han, Zhihui Zhang
INTRODUCTION: Primary Sjögren's syndrome (pSS) is an autoimmune disease characterized by inflammatory infiltration, and dysfunction of the salivary and lacrimal glands. This research aimed to explore the disease pathogenesis and improve the diagnosis and treatment of pSS by mining inflammation-associated biomarkers. METHODS: Five pSS-related datasets were retrieved from the Gene Expression Omnibus (GEO) database. Inflammation-associated biomarkers were determined by the least absolute shrinkage and selection operator (LASSO) and support vector machines recursive feature elimination (SVM-RFE)...
February 20, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38367478/modulation-of-cd8-t-cells-nk-cells-and-th1cytokines-by-metabolic-milieu-in-decline-of-hbv-viremia-in-pregnant-women-treated-with-tenofovir-disoproxil-from-second-trimester-of-pregnancy
#13
JOURNAL ARTICLE
Prabhjyoti Pahwa, Ashish Kumar Vyas, Jayesh Kumar Sevak, Ravinder Singh, Jaswinder Singh Maras, Sharda Patra, Shiv K Sarin, Nirupama Trehanpati
High HBV DNA levels predispose to mother to child transmission (MTCT) of HBV. Early nucleotide analogue (NA) therapy can reduce HBV DNA and minimize MTCT. We analysed immune-metabolic profile in pregnant mothers who received NA from 2nd trimester compared with untreated mothers. In 2nd trimester, there was no difference in immune profiles between Gr.1 and Gr.2 but high viral load women had downregulated pyruvate, NAD+ metabolism but in 3rd trimester, Gr.1 had significant reduction in HBV-DNA, upregulated pyruvate and NAD with increased IFN-2αA, CD8Tcells, NK cells and decreased Tregs, IL15, IL18, IL29, TGFβ3 compared to Gr...
January 28, 2024: Journal of Reproductive Immunology
https://read.qxmd.com/read/38362844/comparison-of-immune-related-gene-signatures-and-immune-infiltration-features-in-early-and-late-onset-preeclampsia
#14
JOURNAL ARTICLE
Quanfeng Wu, Xiang Ying, Weiwei Yu, Huanxi Li, Wei Wei, Xueyan Lin, Meilin Yang, Xueqin Zhang
BACKGROUND: Preeclampsia, a severe pregnancy syndrome, is widely accepted divided into early- and late-onset preeclampsia (EOPE and LOPE) based on the onset time of preeclampsia, with distinct pathophysiological origins. However, the molecular mechanism especially immune-related mechanisms for EOPE and LOPE is currently obscure. In the present study, we focused on placental immune alterations between EOPE and LOPE and search for immune-related biomarkers that could potentially serve as potential therapeutic targets through bioinformatic analysis...
February 2024: Journal of Gene Medicine
https://read.qxmd.com/read/38359930/correction-genetic-variants-in-il15-associate-with-progression-of-joint-destruction-in-rheumatoid-arthritis-a-multicohort-study
#15
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 15, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/38334638/dual-targeting-of-glioblastoma-cells-with-bispecific-killer-cell-engagers-directed-to-egfr-and-erbb2-her2-facilitates-effective-elimination-by-nkg2d-car-engineered-nk-cells
#16
JOURNAL ARTICLE
Anne Kiefer, Maren Prüfer, Jasmin Röder, Jordi Pfeifer Serrahima, Malena Bodden, Ines Kühnel, Pranav Oberoi, Winfried S Wels
NKG2D is an activating receptor of natural killer cells that recognizes stress-induced ligands (NKG2DL) expressed by many tumor cells. Nevertheless, NKG2DL downregulation or shedding can still allow cancer cells to evade immune surveillance. Here, we used lentiviral gene transfer to engineer clinically usable NK-92 cells with a chimeric antigen receptor (NKAR) which contains the extracellular domain of NKG2D for target recognition, or an NKAR, together with the IL-15 superagonist RD-IL15, and combined these effector cells with recombinant NKG2D-interacting bispecific engagers that simultaneously recognize the tumor-associated antigens epidermal growth factor receptor (EGFR) or ErbB2 (HER2)...
January 28, 2024: Cells
https://read.qxmd.com/read/38319717/innate-immunity-activation-in-newly-diagnosed-ileocolonic-crohn-s-disease-a-cohort-study
#17
JOURNAL ARTICLE
Imerio Angriman, Giovanni Bordignon, Andromachi Kotsafti, Claudia Mescoli, Melania Scarpa, Cesare Ruffolo, Matteo Fassan, Angelo Paolo Dei Tos, Renata D'Incà, Edoardo Savarino, Fabiana Zingone, Salvatore Pucciarelli, Romeo Bardini, Ignazio Castagliuolo, Marco Scarpa
BACKGROUND: Recent studies showed that early surgery for Crohn's disease leads to a lower recurrence rate. However, the underlying mechanism is unknown. OBJECTIVE: The study aims to analyze the innate immunity microenvironment in ileal mucosa according to Crohn's disease duration. DESIGN: A prospective cohort study. SETTINGS: Tertiary referral center for IBD surgery. PATIENTS: A total of 88 consecutive Crohn's disease patients undergoing ileocolonic resection were prospectively enrolled...
February 6, 2024: Diseases of the Colon and Rectum
https://read.qxmd.com/read/38285375/validation-of-new-immune-and-inflammation-related-diagnostic-biomarkers-for-ra
#18
JOURNAL ARTICLE
Xijie Bao
BACKGROUND: Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease, whose development is associated with immune cells and persistent inflammation. Exploring the biomarkers of RA holds immense significance in terms of the prevention, diagnosis, and treatment of RA. MATERIAL AND METHODS: The differentially expressed genes (DEGs) in RA patients and the control group were screened by limma package. Through DEGs intersection overlapping 200 inflammatory response-related genes and 2498 immune-related genes, differentially expressed immune and inflammation-related genes (DE-IIRGs) were identified...
January 29, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38282832/use-of-rna-seq-to-identify-genes-encoding-cytokines-and-chemokines-activated-following-uptake-and-processing-a-candidate-peptide-vaccine-developed-against-mycobacterium-avium-subsp-paratuberculosis
#19
JOURNAL ARTICLE
Michelle Athena Decourcey, William Charles Davis, Cleverson de Souza
Analysis of the primary and recall responses to a membrane molecule (MMP), encoded by MAP2121c demonstrated that tri-directional signaling between the antigen-presenting cell (APC), CD4 and CD8 is essential for eliciting a CD8 cytotoxic T cell (CTL) response against Mycobacterium avium subsp. paratuberculosis. As reported here, RNA-sequencing was used to initiate the characterization of the signaling pathways involved in eliciting the development of CD8 CTL, starting with the characterization of the activation status of genes in monocyte-derived macrophages (MoMΦ) following uptake and processing MMP for the presentation of antigenic epitopes to CD4 and CD8 T cells...
2024: Braz J Vet Med
https://read.qxmd.com/read/38104097/integrative-analysis-of-transcriptomic-and-metabolomic-profiles-reveals-enhanced-arginine-metabolism-in-androgen-independent-prostate-cancer-cells
#20
JOURNAL ARTICLE
Xingchen Dai, Xinyi Shi, Mingxiu Luo, Pu Li, Yujing Gao
BACKGROUND: Prostate cancer is a common solid tumor that affects a significant number of men worldwide. Conventional androgen deprivation therapy (ADT) increases the risk of developing castration-resistant prostate cancer (CRPC). Effective clinical management of patients with CRPC is challenging due to the limited understanding. METHODS: In this study, transcriptomic and metabolomic profiles of androgen-dependent prostate cancer cell line LNCaP and the androgen-independent cells developed from LNCaP cells (LNCaP-ADR) were investigated using RNA-sequencing and LC-MS/MS, respectively...
December 16, 2023: BMC Cancer
keyword
keyword
1989
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.